ReviewCurrent cancer drug targets2025
Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology.
Review in Current cancer drug targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is the second most common cause of death worldwide and one of the biggest public health issues arising day by day. Cancer treatment has experienced significant progressions in recent years, as emerging technologies have provided innovative strategies to combat this intricate ailment. Among these developments, nanotechnology has shown itself to be a potentially useful tool in the fight against cancer. In the last few years, there have been several researches performed in the field of nanoparticles because of their several advantages as compared to conventional drug delivery using nanoparticles along with updating technologies like artificial intelligence (AI). The use of nanoparticles decreases the chance of undesirable side effects and shows its action on the targeted site with the help of designed carriers.AI based nanoparticles can't only be used for achieving the targeted site of action but can also help us in advanced imaging, drug release and optimizing the drug delivery in a more customized way, which opens the door of a new era for tailored made medicine.
Indexed as
Identifiers
39473110What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.